home / stock / khrn:cc / khrn:cc news


KHRN:CC News and Press, Khiron Life Sciences Corp. From 06/02/22

Stock Information

Company Name: Khiron Life Sciences Corp.
Stock Symbol: KHRN:CC
Market: TSXVC

Menu

KHRN:CC KHRN:CC Quote KHRN:CC Short KHRN:CC News KHRN:CC Articles KHRN:CC Message Board
Get KHRN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...

KHRN:CC - IIROC Trading Halt - KHRN

IIROC Trading Halt - KHRN Canada NewsWire VANCOUVER, BC , June 2, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Khiron Life Sciences Corp. TSX-Venture Symbol: KHRN All Issues: Yes Reason: At the Request of the Company P...

KHRN:CC - KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING

KHIRON LIFE SCIENCES ANNOUNCES OVERNIGHT BROKERED OFFERING Canada NewsWire /NOT FOR ‎DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE ‎DISSEMINATION, DISTRIBUTION, ‎RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE U...

KHRN:CC - Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint

Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint Canada NewsWire The acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining di...

KHRN:CC - PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khiron

Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (" PharmaDrug " or the " Company "), is pleased to announce that it has entered into an agreement on May 31, 2022 with Khiron Life Sciences Corp. (TSXV: KHRN) (" Khiron ") to sell all of the outstand...

KHRN:CC - Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis

Khiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical Cannabis Canada NewsWire The Corporation recorded revenues of $4.6 million in Q1 2022, a 65% increase from Q1 2021, and a 28% increase from Q4 2021 Record revenue i...

KHRN:CC - Khiron to Host First Quarter 2022 Conference Call on May 31, 2022

Khiron to Host First Quarter 2022 Conference Call on May 31, 2022 Canada NewsWire TORONTO , May 25, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMXC), the global medical cannabis...

KHRN:CC - Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022

Khiron achieves United Kingdom Cannabis Sales Volume Growth of 240% in Q1 2022 Canada NewsWire In Q1 2022, Khiron expects to surpass 1 million CAD in medical cannabis revenues in the United Kingdom ("UK") alone Total untapped potential for cannabis pati...

KHRN:CC - Khiron Life Sciences Reports 2021 Fiscal Year End Results

Khiron Life Sciences Reports 2021 Fiscal Year End Results Canada NewsWire 2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation's medical cannabis sales in 2021 increased to $4.6 million , representing 36% of t...

KHRN:CC - Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022

Khiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022 Canada NewsWire TORONTO , April 27, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMZC), the global medical cannab...

KHRN:CC - Global Medical Cannabis Leader Khiron Opens New Zerenia(TM) Clinic and Retail Pharmacy in Colombia

Global Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in Colombia Canada NewsWire Continues market leadership in Colombia , Latin America's only country with universal health coverage for medical cannabis Market leader i...

Previous 10 Next 10